Inside the tactical tug of war over the controversial Alzheimer's drug
The drug industry, patient advocates and congressional Republicans have all attacked federal officials' decision to decline routine Medicare coverage for a controversial Alzheimer's drug. They've gone as far as to accuse ...
Feb 17, 2022
0
7